Posts tagged “Targacept ”
Payment for rights to depression drug drives up Targacept’s losses
CEO calls 2009 a “breakthrough year” for the Winston-Salem based biopharmaceutical firm.
Targacept receives $304,000 grant from Michael J. Fox Foundation
The funding, which is the second the foundation has awarded to Targacept, will be used in research to combat Parkinson’s Disease.
AstraZeneca makes $200 million drug development payment to Targacept
Two companies are developing a potential treatment for depression. Deal could be worth more than $1 billion for Targacept.
Targacept lands potential $1.2 billion deal with AstraZeneca
Winston-Salem-based drug development firm partners with drug giant on development of a potential blockbuster treatment for depression.
Targacept set for inclusion in NASDAQ biotech index
The company met criteria for market capitalization and trading volume.
Trial results spark stampede for Targacept stock
Shares reach all-time high of $24.50 Friday after Winston-Salem drug company discloses strong results for a depression drug candidate. Last December, Targacept shares traded at $1.40. One analyst calls compound a potential blockbuster.
